Recent Stories
Whistleblower Laws Call for Sound, Clearly Defined Policies
A tidal wave of new lawsuits claiming retaliation against so-called whistleblowers has been hitting business owners in recent years.
August 15, 2014 4:13 p.m. share »
More Biotech Firms Head to ATM for Cash
Publicly held biotechnology companies are increasingly going the ATM route to raise capital, said Todd Wyche, co-founder and managing director of New York-based investment firm Brinson Patrick Securities Corp., which has an office in La Jolla.
April 9, 2012 midnight share »
$37M Sale of Assets Helps Verenium Say Goodbye to Debt
Verenium Corp., a San Diego-based industrial biotechnology company, has closed on a $37 million sale of its oilseed processing business and other assets to the food and beverage unit of Royal DSM N.V., a multinational science company with headquarters in the Netherlands.
April 9, 2012 midnight share »
OncoSec Inches Ahead on Skin Cancer Zapping Technology
San Diego-based OncoSec Medical Inc. is making headway on a unique approach to treat the highly aggressive form of skin cancer known as Merkel cell carcinoma, said CEO Punit Dhillon.
April 9, 2012 midnight share »
UCSD Hospital Breaks Ground
Sleek architectural renderings of UC San Diego Health System’s future medical center in La Jolla are what first caught the attention of Irwin Jacobs more than two years ago.
April 9, 2012 midnight share »Illumina’s Board Not Impressed by Roche’s Revised Takeover Bid
San Diego-based gene sequencing giant Illumina Inc. on April 2 rejected Roche Holding AG’s revised takeover bid, which values the company at about $6.7 billion.
April 3, 2012 12:05 a.m. share »Sapphire Raises $144M in Series C Funding to Commercialize Green Crude
San Diego-based Sapphire Energy Inc., which is using algae to produce “green crude” oil that can be used for fuel, has raised $144 million in Series C investment financing.
April 3, 2012 12:02 a.m. share »
Amylin Shares Soar; Company Spurns Offer
Shares of Amylin Pharmaceuticals Inc. jumped March 28 in the wake of a news report that the diabetes-focused pharmaceutical company had rejected a $3.5 billion unsolicited takeover offer from Bristol-Myers Squibb Co. earlier this year.
April 2, 2012 midnight share »
Biopharmaceutical Firm Expects $7.75 Million From Public Offering
OncoSec Medical Inc., a San Diego-based biopharmaceutical company that’s developing therapies to treat solid tumor cancers, expects to raise $7.75 million in gross proceeds through a public stock offering.
April 2, 2012 midnight share »
Millennium Labs Leads Effort to Establish Industrywide Code of Ethics
It’s like the Wild, Wild West in the pain-medication monitoring industry, say leaders at San Diego-based Millennium Laboratories Inc.
April 2, 2012 midnight share »
